PT Suparma Tbk (IDX: SPMA)
Indonesia
· Delayed Price · Currency is IDR 298.00
-2.00 (-0.67%)
Dec 20, 2024, 4:00 PM WIB
PT Suparma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,668,169 | 2,658,521 | 3,138,054 | 2,794,453 | 2,151,495 | 2,514,161 | Upgrade
|
| Revenue Growth (YoY) | -2.35% | -15.28% | 12.30% | 29.88% | -14.42% | 5.23% | Upgrade
|
| Cost of Revenue | 2,241,898 | 2,196,750 | 2,427,849 | 2,212,061 | 1,765,848 | 2,148,787 | Upgrade
|
| Gross Profit | 426,271 | 461,771 | 710,205 | 582,392 | 385,647 | 365,375 | Upgrade
|
| Selling, General & Admin | 211,180 | 206,708 | 183,723 | 169,709 | 154,023 | 170,607 | Upgrade
|
| Other Operating Expenses | - | - | 613.51 | - | 2,560 | 6,346 | Upgrade
|
| Operating Expenses | 211,180 | 206,708 | 184,337 | 169,709 | 156,583 | 176,953 | Upgrade
|
| Operating Income | 215,091 | 255,063 | 525,868 | 412,683 | 229,064 | 188,422 | Upgrade
|
| Interest Expense | -37,212 | -34,876 | -32,682 | -31,355 | -33,558 | -47,029 | Upgrade
|
| Interest & Investment Income | 7,531 | 5,809 | 4,247 | 1,344 | 2,783 | 2,874 | Upgrade
|
| Currency Exchange Gain (Loss) | 15,165 | 9,086 | -65,997 | 335.94 | -2,217 | 31,025 | Upgrade
|
| Other Non Operating Income (Expenses) | -2,559 | 3,042 | 632.25 | 3,373 | -568.22 | -1,046 | Upgrade
|
| EBT Excluding Unusual Items | 198,015 | 238,124 | 432,068 | 386,381 | 195,503 | 174,246 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2,178 | -461.94 | -622.47 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 186.72 | - | - | - | 2,394 | Upgrade
|
| Other Unusual Items | - | - | - | -8,871 | - | - | Upgrade
|
| Pretax Income | 200,193 | 237,849 | 431,446 | 377,510 | 195,503 | 176,640 | Upgrade
|
| Income Tax Expense | 50,398 | 59,190 | 95,308 | 83,184 | 32,979 | 45,635 | Upgrade
|
| Net Income | 149,795 | 178,658 | 336,138 | 294,326 | 162,525 | 131,006 | Upgrade
|
| Net Income to Common | 149,795 | 178,658 | 336,138 | 294,326 | 162,525 | 131,006 | Upgrade
|
| Net Income Growth | -35.83% | -46.85% | 14.21% | 81.10% | 24.06% | 59.31% | Upgrade
|
| Shares Outstanding (Basic) | 3,154 | 3,154 | 3,154 | 3,154 | 3,154 | 3,154 | Upgrade
|
| Shares Outstanding (Diluted) | 3,154 | 3,154 | 3,154 | 3,154 | 3,154 | 3,154 | Upgrade
|
| Shares Change (YoY) | - | - | - | -0.00% | - | - | Upgrade
|
| EPS (Basic) | 47.49 | 56.64 | 106.57 | 93.32 | 51.53 | 41.54 | Upgrade
|
| EPS (Diluted) | 47.49 | 56.64 | 106.57 | 93.32 | 51.53 | 41.54 | Upgrade
|
| EPS Growth | -35.83% | -46.85% | 14.21% | 81.10% | 24.06% | 59.31% | Upgrade
|
| Free Cash Flow | 627,073 | 654,950 | 862,153 | 744,770 | 640,090 | -19,624 | Upgrade
|
| Free Cash Flow Per Share | 198.81 | 207.65 | 273.34 | 236.13 | 202.94 | -6.22 | Upgrade
|
| Dividend Per Share | 12.000 | 12.000 | - | - | 10.056 | - | Upgrade
|
| Gross Margin | 15.98% | 17.37% | 22.63% | 20.84% | 17.92% | 14.53% | Upgrade
|
| Operating Margin | 8.06% | 9.59% | 16.76% | 14.77% | 10.65% | 7.49% | Upgrade
|
| Profit Margin | 5.61% | 6.72% | 10.71% | 10.53% | 7.55% | 5.21% | Upgrade
|
| Free Cash Flow Margin | 23.50% | 24.64% | 27.47% | 26.65% | 29.75% | -0.78% | Upgrade
|
| EBITDA | 320,004 | 352,014 | 616,613 | 493,098 | 322,469 | 277,540 | Upgrade
|
| EBITDA Margin | 11.99% | 13.24% | 19.65% | 17.65% | 14.99% | 11.04% | Upgrade
|
| D&A For EBITDA | 104,914 | 96,951 | 90,745 | 80,415 | 93,406 | 89,118 | Upgrade
|
| EBIT | 215,091 | 255,063 | 525,868 | 412,683 | 229,064 | 188,422 | Upgrade
|
| EBIT Margin | 8.06% | 9.59% | 16.76% | 14.77% | 10.65% | 7.49% | Upgrade
|
| Effective Tax Rate | 25.17% | 24.89% | 22.09% | 22.03% | 16.87% | 25.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.